nodes	percent_of_prediction	percent_of_DWPC	metapath
Omeprazole—CYP2C9—brain cancer	0.368	1	CbGaD
Omeprazole—CYP1B1—Procarbazine—brain cancer	0.209	0.461	CbGbCtD
Omeprazole—ABCC3—Etoposide—brain cancer	0.0497	0.11	CbGbCtD
Omeprazole—CYP2D6—Lomustine—brain cancer	0.0287	0.0633	CbGbCtD
Omeprazole—CYP1A2—Carmustine—brain cancer	0.0284	0.0627	CbGbCtD
Omeprazole—ABCG2—Carboplatin—brain cancer	0.0243	0.0537	CbGbCtD
Omeprazole—CYP2D6—Hydroxyurea—brain cancer	0.0218	0.048	CbGbCtD
Omeprazole—CYP3A4—Temozolomide—brain cancer	0.0215	0.0474	CbGbCtD
Omeprazole—ABCG2—Etoposide—brain cancer	0.0204	0.045	CbGbCtD
Omeprazole—CYP3A4—Lomustine—brain cancer	0.0183	0.0403	CbGbCtD
Omeprazole—CYP2C8—Etoposide—brain cancer	0.0109	0.024	CbGbCtD
Omeprazole—CYP1A2—Etoposide—brain cancer	0.00843	0.0186	CbGbCtD
Omeprazole—ABCB1—Etoposide—brain cancer	0.00737	0.0162	CbGbCtD
Omeprazole—CYP3A4—Etoposide—brain cancer	0.00442	0.00973	CbGbCtD
Omeprazole—CYP11A1—Prostaglandin Synthesis and Regulation—S100A10—brain cancer	0.0013	0.0264	CbGpPWpGaD
Omeprazole—CYP2C18—Xenobiotics—CYP2C9—brain cancer	0.00129	0.0262	CbGpPWpGaD
Omeprazole—CYP2C8—Arachidonate Epoxygenase / Epoxide Hydrolase—CYP2C9—brain cancer	0.00125	0.0253	CbGpPWpGaD
Omeprazole—Rabeprazole—CYP2C9—brain cancer	0.00122	0.364	CrCbGaD
Omeprazole—Pantoprazole—CYP2C9—brain cancer	0.00122	0.364	CrCbGaD
Omeprazole—CYP1A1—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00122	0.0248	CbGpPWpGaD
Omeprazole—CYP2C8—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00112	0.0227	CbGpPWpGaD
Omeprazole—CYP1A1—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00111	0.0225	CbGpPWpGaD
Omeprazole—CYP2C8—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00102	0.0207	CbGpPWpGaD
Omeprazole—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.001	0.0203	CbGpPWpGaD
Omeprazole—CYP1B1—Tamoxifen metabolism—CYP2C9—brain cancer	0.000917	0.0186	CbGpPWpGaD
Omeprazole—Lansoprazole—CYP2C9—brain cancer	0.000911	0.272	CrCbGaD
Omeprazole—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00091	0.0184	CbGpPWpGaD
Omeprazole—CYP2C8—CYP2E1 reactions—CYP2C9—brain cancer	0.000869	0.0176	CbGpPWpGaD
Omeprazole—ABCC3—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000864	0.0175	CbGpPWpGaD
Omeprazole—ABCC3—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000823	0.0167	CbGpPWpGaD
Omeprazole—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.000779	0.0158	CbGpPWpGaD
Omeprazole—ATP4B—endocrine gland—brain cancer	0.000777	0.085	CbGeAlD
Omeprazole—CYP2C19—CYP2E1 reactions—CYP2C9—brain cancer	0.000775	0.0157	CbGpPWpGaD
Omeprazole—CYP2D6—CYP2E1 reactions—CYP2C9—brain cancer	0.000713	0.0144	CbGpPWpGaD
Omeprazole—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.000709	0.0144	CbGpPWpGaD
Omeprazole—CYP11A1—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000621	0.0126	CbGpPWpGaD
Omeprazole—CYP11A1—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000613	0.0124	CbGpPWpGaD
Omeprazole—CYP1A1—Xenobiotics—CYP2C9—brain cancer	0.000587	0.0119	CbGpPWpGaD
Omeprazole—CYP1A1—Tamoxifen metabolism—CYP2C9—brain cancer	0.000565	0.0114	CbGpPWpGaD
Omeprazole—CYP2C8—Xenobiotics—CYP2C9—brain cancer	0.000538	0.0109	CbGpPWpGaD
Omeprazole—CYP2C18—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000537	0.0109	CbGpPWpGaD
Omeprazole—CYP2C18—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.00053	0.0107	CbGpPWpGaD
Omeprazole—CYP2C8—Tamoxifen metabolism—CYP2C9—brain cancer	0.000518	0.0105	CbGpPWpGaD
Omeprazole—CYP11A1—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000503	0.0102	CbGpPWpGaD
Omeprazole—CYP2C19—Xenobiotics—CYP2C9—brain cancer	0.000481	0.00973	CbGpPWpGaD
Omeprazole—CYP2C19—Tamoxifen metabolism—CYP2C9—brain cancer	0.000462	0.00936	CbGpPWpGaD
Omeprazole—CYP1B1—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000458	0.00928	CbGpPWpGaD
Omeprazole—CYP2D6—Xenobiotics—CYP2C9—brain cancer	0.000442	0.00895	CbGpPWpGaD
Omeprazole—ATP4B—Ion channel transport—TRPC6—brain cancer	0.000436	0.00883	CbGpPWpGaD
Omeprazole—CYP2C18—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000435	0.00882	CbGpPWpGaD
Omeprazole—CYP2D6—Tamoxifen metabolism—CYP2C9—brain cancer	0.000425	0.00861	CbGpPWpGaD
Omeprazole—CYP2C18—FOXA1 transcription factor network—SHH—brain cancer	0.000398	0.00806	CbGpPWpGaD
Omeprazole—CYP1B1—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000396	0.00802	CbGpPWpGaD
Omeprazole—CYP1B1—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000391	0.00791	CbGpPWpGaD
Omeprazole—ATP4A—Ion channel transport—TRPC6—brain cancer	0.000389	0.00787	CbGpPWpGaD
Omeprazole—CYP1A2—Xenobiotics—CYP2C9—brain cancer	0.000374	0.00758	CbGpPWpGaD
Omeprazole—CYP1A2—Tamoxifen metabolism—CYP2C9—brain cancer	0.00036	0.00729	CbGpPWpGaD
Omeprazole—ATP4A—endocrine gland—brain cancer	0.000338	0.037	CbGeAlD
Omeprazole—ATP4A—head—brain cancer	0.000334	0.0365	CbGeAlD
Omeprazole—CYP2C19—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.00033	0.00668	CbGpPWpGaD
Omeprazole—ATP4B—Transmembrane transport of small molecules—S100A10—brain cancer	0.000329	0.00666	CbGpPWpGaD
Omeprazole—ABCB1—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000322	0.00652	CbGpPWpGaD
Omeprazole—CYP1B1—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000321	0.0065	CbGpPWpGaD
Omeprazole—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000307	0.00621	CbGpPWpGaD
Omeprazole—ABCG2—Irinotecan Pathway—APC—brain cancer	0.000306	0.0062	CbGpPWpGaD
Omeprazole—ATP4A—central nervous system—brain cancer	0.000305	0.0333	CbGeAlD
Omeprazole—ATP4A—cerebellum—brain cancer	0.000298	0.0326	CbGeAlD
Omeprazole—CYP11A1—gonad—brain cancer	0.000293	0.0321	CbGeAlD
Omeprazole—ATP4A—Transmembrane transport of small molecules—S100A10—brain cancer	0.000293	0.00593	CbGpPWpGaD
Omeprazole—CYP3A4—Xenobiotics—CYP2C9—brain cancer	0.000289	0.00585	CbGpPWpGaD
Omeprazole—CYP1A1—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000282	0.00571	CbGpPWpGaD
Omeprazole—CYP2C18—endocrine gland—brain cancer	0.000278	0.0304	CbGeAlD
Omeprazole—CYP3A4—Tamoxifen metabolism—CYP2C9—brain cancer	0.000278	0.00563	CbGpPWpGaD
Omeprazole—CYP11A1—medulla oblongata—brain cancer	0.000276	0.0302	CbGeAlD
Omeprazole—CYP11A1—Biological oxidations—CYP2C9—brain cancer	0.000267	0.00541	CbGpPWpGaD
Omeprazole—CYP11A1—Metapathway biotransformation—CYP2C9—brain cancer	0.000264	0.00534	CbGpPWpGaD
Omeprazole—CYP2C8—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000259	0.00524	CbGpPWpGaD
Omeprazole—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000245	0.00496	CbGpPWpGaD
Omeprazole—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000244	0.00494	CbGpPWpGaD
Omeprazole—ATP4A—brain—brain cancer	0.000242	0.0265	CbGeAlD
Omeprazole—CYP1A1—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000241	0.00487	CbGpPWpGaD
Omeprazole—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—SKP2—brain cancer	0.000232	0.0047	CbGpPWpGaD
Omeprazole—CYP2C18—Biological oxidations—CYP2C9—brain cancer	0.000231	0.00468	CbGpPWpGaD
Omeprazole—CYP2C19—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000231	0.00468	CbGpPWpGaD
Omeprazole—CYP2C18—Metapathway biotransformation—CYP2C9—brain cancer	0.000228	0.00462	CbGpPWpGaD
Omeprazole—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000224	0.00453	CbGpPWpGaD
Omeprazole—CYP11A1—endocrine gland—brain cancer	0.000222	0.0243	CbGeAlD
Omeprazole—CYP2C8—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000221	0.00447	CbGpPWpGaD
Omeprazole—CYP11A1—head—brain cancer	0.000219	0.0239	CbGeAlD
Omeprazole—CYP2D6—hindbrain—brain cancer	0.000214	0.0234	CbGeAlD
Omeprazole—CYP1B1—telencephalon—brain cancer	0.000213	0.0234	CbGeAlD
Omeprazole—ABCG2—HIF-2-alpha transcription factor network—SIRT1—brain cancer	0.000211	0.00428	CbGpPWpGaD
Omeprazole—CYP1B1—Estrogen Receptor Pathway—STAT3—brain cancer	0.000211	0.00428	CbGpPWpGaD
Omeprazole—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—brain cancer	0.000207	0.00419	CbGpPWpGaD
Omeprazole—Depression—Temozolomide—brain cancer	0.000203	0.00175	CcSEcCtD
Omeprazole—Stevens-Johnson syndrome—Temozolomide—brain cancer	0.000202	0.00174	CcSEcCtD
Omeprazole—Nausea—Lomustine—brain cancer	0.000201	0.00173	CcSEcCtD
Omeprazole—CYP11A1—central nervous system—brain cancer	0.0002	0.0219	CbGeAlD
Omeprazole—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.0002	0.00404	CbGpPWpGaD
Omeprazole—Stomatitis—Temozolomide—brain cancer	0.000199	0.00171	CcSEcCtD
Omeprazole—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000198	0.00402	CbGpPWpGaD
Omeprazole—Urinary tract infection—Temozolomide—brain cancer	0.000198	0.00171	CcSEcCtD
Omeprazole—CYP1A1—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000198	0.004	CbGpPWpGaD
Omeprazole—CYP2C19—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000197	0.00399	CbGpPWpGaD
Omeprazole—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000196	0.00169	CcSEcCtD
Omeprazole—Insomnia—Procarbazine—brain cancer	0.000195	0.00168	CcSEcCtD
Omeprazole—Paraesthesia—Procarbazine—brain cancer	0.000193	0.00166	CcSEcCtD
Omeprazole—Hepatobiliary disease—Temozolomide—brain cancer	0.000193	0.00166	CcSEcCtD
Omeprazole—Sinusitis—Temozolomide—brain cancer	0.000191	0.00165	CcSEcCtD
Omeprazole—Somnolence—Procarbazine—brain cancer	0.000191	0.00165	CcSEcCtD
Omeprazole—Cramp muscle—Etoposide—brain cancer	0.000191	0.00164	CcSEcCtD
Omeprazole—Toxic epidermal necrolysis—Etoposide—brain cancer	0.000191	0.00164	CcSEcCtD
Omeprazole—Ill-defined disorder—Hydroxyurea—brain cancer	0.000189	0.00163	CcSEcCtD
Omeprazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000189	0.00383	CbGpPWpGaD
Omeprazole—Anaemia—Hydroxyurea—brain cancer	0.000189	0.00162	CcSEcCtD
Omeprazole—Hallucination—Carmustine—brain cancer	0.000189	0.00162	CcSEcCtD
Omeprazole—Hypoaesthesia—Carmustine—brain cancer	0.000189	0.00162	CcSEcCtD
Omeprazole—Decreased appetite—Procarbazine—brain cancer	0.000187	0.00161	CcSEcCtD
Omeprazole—Alanine aminotransferase increased—Etoposide—brain cancer	0.000187	0.00161	CcSEcCtD
Omeprazole—Oedema peripheral—Carmustine—brain cancer	0.000187	0.00161	CcSEcCtD
Omeprazole—Connective tissue disorder—Carmustine—brain cancer	0.000186	0.0016	CcSEcCtD
Omeprazole—Fatigue—Procarbazine—brain cancer	0.000185	0.0016	CcSEcCtD
Omeprazole—Malaise—Hydroxyurea—brain cancer	0.000184	0.00158	CcSEcCtD
Omeprazole—Constipation—Procarbazine—brain cancer	0.000184	0.00158	CcSEcCtD
Omeprazole—Pain—Procarbazine—brain cancer	0.000184	0.00158	CcSEcCtD
Omeprazole—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000184	0.00372	CbGpPWpGaD
Omeprazole—Hepatitis—Temozolomide—brain cancer	0.000183	0.00158	CcSEcCtD
Omeprazole—Dysphagia—Etoposide—brain cancer	0.000183	0.00158	CcSEcCtD
Omeprazole—Leukopenia—Hydroxyurea—brain cancer	0.000183	0.00157	CcSEcCtD
Omeprazole—Visual impairment—Carmustine—brain cancer	0.000183	0.00157	CcSEcCtD
Omeprazole—Hypoaesthesia—Temozolomide—brain cancer	0.000182	0.00157	CcSEcCtD
Omeprazole—Hallucination—Temozolomide—brain cancer	0.000182	0.00157	CcSEcCtD
Omeprazole—Pharyngitis—Temozolomide—brain cancer	0.000182	0.00156	CcSEcCtD
Omeprazole—CYP2C8—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000181	0.00367	CbGpPWpGaD
Omeprazole—CYP2D6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000181	0.00367	CbGpPWpGaD
Omeprazole—Urinary tract disorder—Temozolomide—brain cancer	0.000181	0.00156	CcSEcCtD
Omeprazole—Oedema peripheral—Temozolomide—brain cancer	0.00018	0.00155	CcSEcCtD
Omeprazole—Bronchospasm—Etoposide—brain cancer	0.00018	0.00155	CcSEcCtD
Omeprazole—Connective tissue disorder—Temozolomide—brain cancer	0.00018	0.00155	CcSEcCtD
Omeprazole—CYP1A2—Arachidonic acid metabolism—CYP2C9—brain cancer	0.00018	0.00364	CbGpPWpGaD
Omeprazole—Urethral disorder—Temozolomide—brain cancer	0.000179	0.00155	CcSEcCtD
Omeprazole—Sweating increased—Etoposide—brain cancer	0.000178	0.00154	CcSEcCtD
Omeprazole—CYP1B1—gonad—brain cancer	0.000178	0.0195	CbGeAlD
Omeprazole—Feeling abnormal—Procarbazine—brain cancer	0.000177	0.00153	CcSEcCtD
Omeprazole—Eye disorder—Carmustine—brain cancer	0.000177	0.00152	CcSEcCtD
Omeprazole—Visual impairment—Temozolomide—brain cancer	0.000176	0.00152	CcSEcCtD
Omeprazole—Gastrointestinal pain—Procarbazine—brain cancer	0.000176	0.00151	CcSEcCtD
Omeprazole—CYP1B1—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	0.000176	0.00356	CbGpPWpGaD
Omeprazole—Flushing—Carmustine—brain cancer	0.000176	0.00151	CcSEcCtD
Omeprazole—Pancytopenia—Etoposide—brain cancer	0.000174	0.0015	CcSEcCtD
Omeprazole—CYP1B1—pituitary gland—brain cancer	0.000174	0.019	CbGeAlD
Omeprazole—Erythema multiforme—Temozolomide—brain cancer	0.000173	0.00149	CcSEcCtD
Omeprazole—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.000172	0.00149	CcSEcCtD
Omeprazole—ABCC3—endocrine gland—brain cancer	0.000172	0.0188	CbGeAlD
Omeprazole—Discomfort—Hydroxyurea—brain cancer	0.000172	0.00148	CcSEcCtD
Omeprazole—Neutropenia—Etoposide—brain cancer	0.000171	0.00147	CcSEcCtD
Omeprazole—Eye disorder—Temozolomide—brain cancer	0.000171	0.00147	CcSEcCtD
Omeprazole—Urticaria—Procarbazine—brain cancer	0.000171	0.00147	CcSEcCtD
Omeprazole—Tinnitus—Temozolomide—brain cancer	0.000171	0.00147	CcSEcCtD
Omeprazole—CYP1B1—Biological oxidations—CYP2C9—brain cancer	0.000171	0.00345	CbGpPWpGaD
Omeprazole—Abdominal pain—Procarbazine—brain cancer	0.00017	0.00146	CcSEcCtD
Omeprazole—Body temperature increased—Procarbazine—brain cancer	0.00017	0.00146	CcSEcCtD
Omeprazole—Flushing—Temozolomide—brain cancer	0.00017	0.00146	CcSEcCtD
Omeprazole—ABCC3—head—brain cancer	0.00017	0.0186	CbGeAlD
Omeprazole—CYP1B1—Metapathway biotransformation—CYP2C9—brain cancer	0.000168	0.00341	CbGpPWpGaD
Omeprazole—Alopecia—Carmustine—brain cancer	0.000167	0.00144	CcSEcCtD
Omeprazole—Mental disorder—Carmustine—brain cancer	0.000166	0.00143	CcSEcCtD
Omeprazole—Infection—Hydroxyurea—brain cancer	0.000165	0.00142	CcSEcCtD
Omeprazole—Immune system disorder—Temozolomide—brain cancer	0.000165	0.00142	CcSEcCtD
Omeprazole—Mediastinal disorder—Temozolomide—brain cancer	0.000165	0.00142	CcSEcCtD
Omeprazole—Malnutrition—Carmustine—brain cancer	0.000165	0.00142	CcSEcCtD
Omeprazole—Chills—Temozolomide—brain cancer	0.000164	0.00141	CcSEcCtD
Omeprazole—Nervous system disorder—Hydroxyurea—brain cancer	0.000163	0.00141	CcSEcCtD
Omeprazole—Infestation—Etoposide—brain cancer	0.000163	0.00141	CcSEcCtD
Omeprazole—Infestation NOS—Etoposide—brain cancer	0.000163	0.00141	CcSEcCtD
Omeprazole—Thrombocytopenia—Hydroxyurea—brain cancer	0.000163	0.0014	CcSEcCtD
Omeprazole—Stevens-Johnson syndrome—Etoposide—brain cancer	0.000162	0.00139	CcSEcCtD
Omeprazole—Alopecia—Temozolomide—brain cancer	0.000162	0.00139	CcSEcCtD
Omeprazole—CYP2C19—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000162	0.00328	CbGpPWpGaD
Omeprazole—Skin disorder—Hydroxyurea—brain cancer	0.000162	0.00139	CcSEcCtD
Omeprazole—ABCB1—blood vessel—brain cancer	0.000162	0.0177	CbGeAlD
Omeprazole—Renal failure—Etoposide—brain cancer	0.00016	0.00138	CcSEcCtD
Omeprazole—Mental disorder—Temozolomide—brain cancer	0.00016	0.00138	CcSEcCtD
Omeprazole—Back pain—Carmustine—brain cancer	0.00016	0.00137	CcSEcCtD
Omeprazole—Malnutrition—Temozolomide—brain cancer	0.000159	0.00137	CcSEcCtD
Omeprazole—Stomatitis—Etoposide—brain cancer	0.000159	0.00137	CcSEcCtD
Omeprazole—Jaundice—Etoposide—brain cancer	0.000159	0.00137	CcSEcCtD
Omeprazole—ABCG2—telencephalon—brain cancer	0.000159	0.0174	CbGeAlD
Omeprazole—Anorexia—Hydroxyurea—brain cancer	0.000159	0.00137	CcSEcCtD
Omeprazole—CYP11A1—brain—brain cancer	0.000159	0.0174	CbGeAlD
Omeprazole—Hypersensitivity—Procarbazine—brain cancer	0.000159	0.00136	CcSEcCtD
Omeprazole—Dysgeusia—Temozolomide—brain cancer	0.000156	0.00134	CcSEcCtD
Omeprazole—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000155	0.00315	CbGpPWpGaD
Omeprazole—Vision blurred—Carmustine—brain cancer	0.000155	0.00134	CcSEcCtD
Omeprazole—ABCC3—central nervous system—brain cancer	0.000155	0.017	CbGeAlD
Omeprazole—Tremor—Carmustine—brain cancer	0.000155	0.00133	CcSEcCtD
Omeprazole—Asthenia—Procarbazine—brain cancer	0.000154	0.00133	CcSEcCtD
Omeprazole—Hepatobiliary disease—Etoposide—brain cancer	0.000154	0.00133	CcSEcCtD
Omeprazole—Back pain—Temozolomide—brain cancer	0.000154	0.00133	CcSEcCtD
Omeprazole—CYP1A2—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000153	0.00311	CbGpPWpGaD
Omeprazole—Anaemia—Carmustine—brain cancer	0.000152	0.00131	CcSEcCtD
Omeprazole—Agranulocytosis—Etoposide—brain cancer	0.000152	0.00131	CcSEcCtD
Omeprazole—Pruritus—Procarbazine—brain cancer	0.000152	0.00131	CcSEcCtD
Omeprazole—CYP1A1—Oxidative Stress—SOD2—brain cancer	0.000152	0.00308	CbGpPWpGaD
Omeprazole—ATP4B—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000152	0.00307	CbGpPWpGaD
Omeprazole—Agitation—Carmustine—brain cancer	0.000152	0.0013	CcSEcCtD
Omeprazole—Vision blurred—Temozolomide—brain cancer	0.00015	0.00129	CcSEcCtD
Omeprazole—Tremor—Temozolomide—brain cancer	0.000149	0.00129	CcSEcCtD
Omeprazole—CYP2D6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000149	0.00301	CbGpPWpGaD
Omeprazole—Dyspnoea—Hydroxyurea—brain cancer	0.000148	0.00128	CcSEcCtD
Omeprazole—Somnolence—Hydroxyurea—brain cancer	0.000148	0.00127	CcSEcCtD
Omeprazole—Ill-defined disorder—Temozolomide—brain cancer	0.000148	0.00127	CcSEcCtD
Omeprazole—Leukopenia—Carmustine—brain cancer	0.000148	0.00127	CcSEcCtD
Omeprazole—Anaemia—Temozolomide—brain cancer	0.000147	0.00127	CcSEcCtD
Omeprazole—Diarrhoea—Procarbazine—brain cancer	0.000147	0.00127	CcSEcCtD
Omeprazole—Dyspepsia—Hydroxyurea—brain cancer	0.000147	0.00126	CcSEcCtD
Omeprazole—Agitation—Temozolomide—brain cancer	0.000146	0.00126	CcSEcCtD
Omeprazole—Hypoaesthesia—Etoposide—brain cancer	0.000146	0.00126	CcSEcCtD
Omeprazole—Angioedema—Temozolomide—brain cancer	0.000146	0.00125	CcSEcCtD
Omeprazole—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—brain cancer	0.000145	0.00293	CbGpPWpGaD
Omeprazole—Decreased appetite—Hydroxyurea—brain cancer	0.000145	0.00125	CcSEcCtD
Omeprazole—Urinary tract disorder—Etoposide—brain cancer	0.000145	0.00125	CcSEcCtD
Omeprazole—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000144	0.00124	CcSEcCtD
Omeprazole—Malaise—Temozolomide—brain cancer	0.000144	0.00124	CcSEcCtD
Omeprazole—Urethral disorder—Etoposide—brain cancer	0.000144	0.00124	CcSEcCtD
Omeprazole—Fatigue—Hydroxyurea—brain cancer	0.000144	0.00124	CcSEcCtD
Omeprazole—Vertigo—Temozolomide—brain cancer	0.000143	0.00123	CcSEcCtD
Omeprazole—Leukopenia—Temozolomide—brain cancer	0.000143	0.00123	CcSEcCtD
Omeprazole—Hypertension—Carmustine—brain cancer	0.000142	0.00123	CcSEcCtD
Omeprazole—Pain—Hydroxyurea—brain cancer	0.000142	0.00123	CcSEcCtD
Omeprazole—Constipation—Hydroxyurea—brain cancer	0.000142	0.00123	CcSEcCtD
Omeprazole—Dizziness—Procarbazine—brain cancer	0.000142	0.00122	CcSEcCtD
Omeprazole—Palpitations—Temozolomide—brain cancer	0.000141	0.00121	CcSEcCtD
Omeprazole—Myalgia—Carmustine—brain cancer	0.00014	0.00121	CcSEcCtD
Omeprazole—Chest pain—Carmustine—brain cancer	0.00014	0.00121	CcSEcCtD
Omeprazole—Anxiety—Carmustine—brain cancer	0.00014	0.0012	CcSEcCtD
Omeprazole—Cough—Temozolomide—brain cancer	0.000139	0.0012	CcSEcCtD
Omeprazole—Erythema multiforme—Etoposide—brain cancer	0.000139	0.00119	CcSEcCtD
Omeprazole—Hypertension—Temozolomide—brain cancer	0.000138	0.00118	CcSEcCtD
Omeprazole—Feeling abnormal—Hydroxyurea—brain cancer	0.000137	0.00118	CcSEcCtD
Omeprazole—Eye disorder—Etoposide—brain cancer	0.000137	0.00118	CcSEcCtD
Omeprazole—Vomiting—Procarbazine—brain cancer	0.000137	0.00118	CcSEcCtD
Omeprazole—Flushing—Etoposide—brain cancer	0.000136	0.00117	CcSEcCtD
Omeprazole—Confusional state—Carmustine—brain cancer	0.000136	0.00117	CcSEcCtD
Omeprazole—Arthralgia—Temozolomide—brain cancer	0.000136	0.00117	CcSEcCtD
Omeprazole—Myalgia—Temozolomide—brain cancer	0.000136	0.00117	CcSEcCtD
Omeprazole—Rash—Procarbazine—brain cancer	0.000136	0.00117	CcSEcCtD
Omeprazole—Dermatitis—Procarbazine—brain cancer	0.000136	0.00117	CcSEcCtD
Omeprazole—ATP4A—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000135	0.00274	CbGpPWpGaD
Omeprazole—Anxiety—Temozolomide—brain cancer	0.000135	0.00116	CcSEcCtD
Omeprazole—Headache—Procarbazine—brain cancer	0.000135	0.00116	CcSEcCtD
Omeprazole—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000135	0.00116	CcSEcCtD
Omeprazole—CYP1B1—endocrine gland—brain cancer	0.000135	0.0147	CbGeAlD
Omeprazole—Discomfort—Temozolomide—brain cancer	0.000134	0.00115	CcSEcCtD
Omeprazole—Infection—Carmustine—brain cancer	0.000134	0.00115	CcSEcCtD
Omeprazole—CYP2C8—pituitary gland—brain cancer	0.000133	0.0146	CbGeAlD
Omeprazole—CYP1B1—head—brain cancer	0.000133	0.0145	CbGeAlD
Omeprazole—Dry mouth—Temozolomide—brain cancer	0.000133	0.00114	CcSEcCtD
Omeprazole—Immune system disorder—Etoposide—brain cancer	0.000132	0.00114	CcSEcCtD
Omeprazole—Mediastinal disorder—Etoposide—brain cancer	0.000132	0.00114	CcSEcCtD
Omeprazole—Thrombocytopenia—Carmustine—brain cancer	0.000132	0.00113	CcSEcCtD
Omeprazole—Body temperature increased—Hydroxyurea—brain cancer	0.000132	0.00113	CcSEcCtD
Omeprazole—Chills—Etoposide—brain cancer	0.000131	0.00113	CcSEcCtD
Omeprazole—Tachycardia—Carmustine—brain cancer	0.000131	0.00113	CcSEcCtD
Omeprazole—Confusional state—Temozolomide—brain cancer	0.000131	0.00113	CcSEcCtD
Omeprazole—CYP1A1—Estrogen Receptor Pathway—STAT3—brain cancer	0.00013	0.00264	CbGpPWpGaD
Omeprazole—Anaphylactic shock—Temozolomide—brain cancer	0.00013	0.00112	CcSEcCtD
Omeprazole—Alopecia—Etoposide—brain cancer	0.000129	0.00111	CcSEcCtD
Omeprazole—ABCG2—pituitary gland—brain cancer	0.000129	0.0142	CbGeAlD
Omeprazole—Infection—Temozolomide—brain cancer	0.000129	0.00111	CcSEcCtD
Omeprazole—Anorexia—Carmustine—brain cancer	0.000128	0.0011	CcSEcCtD
Omeprazole—Nausea—Procarbazine—brain cancer	0.000128	0.0011	CcSEcCtD
Omeprazole—Nervous system disorder—Temozolomide—brain cancer	0.000128	0.0011	CcSEcCtD
Omeprazole—Thrombocytopenia—Temozolomide—brain cancer	0.000127	0.0011	CcSEcCtD
Omeprazole—Skin disorder—Temozolomide—brain cancer	0.000126	0.00109	CcSEcCtD
Omeprazole—CYP1A2—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000126	0.00255	CbGpPWpGaD
Omeprazole—Hyperhidrosis—Temozolomide—brain cancer	0.000126	0.00108	CcSEcCtD
Omeprazole—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—SKP2—brain cancer	0.000125	0.00254	CbGpPWpGaD
Omeprazole—ABCG2—medulla oblongata—brain cancer	0.000125	0.0137	CbGeAlD
Omeprazole—Dysgeusia—Etoposide—brain cancer	0.000125	0.00108	CcSEcCtD
Omeprazole—Anorexia—Temozolomide—brain cancer	0.000124	0.00107	CcSEcCtD
Omeprazole—Back pain—Etoposide—brain cancer	0.000123	0.00106	CcSEcCtD
Omeprazole—ABCC3—brain—brain cancer	0.000123	0.0135	CbGeAlD
Omeprazole—CYP2D6—brainstem—brain cancer	0.000123	0.0134	CbGeAlD
Omeprazole—Hypersensitivity—Hydroxyurea—brain cancer	0.000123	0.00106	CcSEcCtD
Omeprazole—Musculoskeletal discomfort—Carmustine—brain cancer	0.000123	0.00106	CcSEcCtD
Omeprazole—Muscle spasms—Etoposide—brain cancer	0.000123	0.00106	CcSEcCtD
Omeprazole—Insomnia—Carmustine—brain cancer	0.000122	0.00105	CcSEcCtD
Omeprazole—CYP1B1—central nervous system—brain cancer	0.000121	0.0133	CbGeAlD
Omeprazole—Paraesthesia—Carmustine—brain cancer	0.000121	0.00104	CcSEcCtD
Omeprazole—Dyspnoea—Carmustine—brain cancer	0.00012	0.00103	CcSEcCtD
Omeprazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.00012	0.00243	CbGpPWpGaD
Omeprazole—Somnolence—Carmustine—brain cancer	0.00012	0.00103	CcSEcCtD
Omeprazole—Asthenia—Hydroxyurea—brain cancer	0.000119	0.00103	CcSEcCtD
Omeprazole—CYP1B1—cerebellum—brain cancer	0.000119	0.013	CbGeAlD
Omeprazole—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000119	0.00102	CcSEcCtD
Omeprazole—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000118	0.0024	CbGpPWpGaD
Omeprazole—Ill-defined disorder—Etoposide—brain cancer	0.000118	0.00102	CcSEcCtD
Omeprazole—CYP2C19—endocrine gland—brain cancer	0.000118	0.0129	CbGeAlD
Omeprazole—Anaemia—Etoposide—brain cancer	0.000118	0.00101	CcSEcCtD
Omeprazole—Insomnia—Temozolomide—brain cancer	0.000118	0.00101	CcSEcCtD
Omeprazole—Decreased appetite—Carmustine—brain cancer	0.000117	0.00101	CcSEcCtD
Omeprazole—Paraesthesia—Temozolomide—brain cancer	0.000117	0.00101	CcSEcCtD
Omeprazole—Gastrointestinal disorder—Carmustine—brain cancer	0.000116	0.001	CcSEcCtD
Omeprazole—Dyspnoea—Temozolomide—brain cancer	0.000116	0.000998	CcSEcCtD
Omeprazole—Somnolence—Temozolomide—brain cancer	0.000116	0.000996	CcSEcCtD
Omeprazole—Pain—Carmustine—brain cancer	0.000115	0.000991	CcSEcCtD
Omeprazole—Constipation—Carmustine—brain cancer	0.000115	0.000991	CcSEcCtD
Omeprazole—Malaise—Etoposide—brain cancer	0.000115	0.00099	CcSEcCtD
Omeprazole—Vertigo—Etoposide—brain cancer	0.000115	0.000987	CcSEcCtD
Omeprazole—Dyspepsia—Temozolomide—brain cancer	0.000114	0.000986	CcSEcCtD
Omeprazole—Leukopenia—Etoposide—brain cancer	0.000114	0.000983	CcSEcCtD
Omeprazole—ABCG2—midbrain—brain cancer	0.000114	0.0125	CbGeAlD
Omeprazole—Diarrhoea—Hydroxyurea—brain cancer	0.000114	0.000981	CcSEcCtD
Omeprazole—Decreased appetite—Temozolomide—brain cancer	0.000113	0.000974	CcSEcCtD
Omeprazole—Gastrointestinal disorder—Temozolomide—brain cancer	0.000112	0.000967	CcSEcCtD
Omeprazole—Fatigue—Temozolomide—brain cancer	0.000112	0.000966	CcSEcCtD
Omeprazole—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—brain cancer	0.000112	0.00227	CbGpPWpGaD
Omeprazole—ABCG2—spinal cord—brain cancer	0.000111	0.0122	CbGeAlD
Omeprazole—Cough—Etoposide—brain cancer	0.000111	0.000958	CcSEcCtD
Omeprazole—Constipation—Temozolomide—brain cancer	0.000111	0.000958	CcSEcCtD
Omeprazole—Pain—Temozolomide—brain cancer	0.000111	0.000958	CcSEcCtD
Omeprazole—Feeling abnormal—Carmustine—brain cancer	0.000111	0.000955	CcSEcCtD
Omeprazole—Hypertension—Etoposide—brain cancer	0.00011	0.000948	CcSEcCtD
Omeprazole—Dizziness—Hydroxyurea—brain cancer	0.00011	0.000948	CcSEcCtD
Omeprazole—Gastrointestinal pain—Carmustine—brain cancer	0.00011	0.000948	CcSEcCtD
Omeprazole—CYP2D6—telencephalon—brain cancer	0.000109	0.0119	CbGeAlD
Omeprazole—Chest pain—Etoposide—brain cancer	0.000109	0.000935	CcSEcCtD
Omeprazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	0.000108	0.00219	CbGpPWpGaD
Omeprazole—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000108	0.000928	CcSEcCtD
Omeprazole—Discomfort—Etoposide—brain cancer	0.000107	0.000924	CcSEcCtD
Omeprazole—Feeling abnormal—Temozolomide—brain cancer	0.000107	0.000923	CcSEcCtD
Omeprazole—Abdominal pain—Carmustine—brain cancer	0.000106	0.000916	CcSEcCtD
Omeprazole—Body temperature increased—Carmustine—brain cancer	0.000106	0.000916	CcSEcCtD
Omeprazole—Gastrointestinal pain—Temozolomide—brain cancer	0.000106	0.000916	CcSEcCtD
Omeprazole—Vomiting—Hydroxyurea—brain cancer	0.000106	0.000911	CcSEcCtD
Omeprazole—CYP1A1—Biological oxidations—CYP2C9—brain cancer	0.000105	0.00213	CbGpPWpGaD
Omeprazole—Rash—Hydroxyurea—brain cancer	0.000105	0.000904	CcSEcCtD
Omeprazole—Confusional state—Etoposide—brain cancer	0.000105	0.000904	CcSEcCtD
Omeprazole—Dermatitis—Hydroxyurea—brain cancer	0.000105	0.000903	CcSEcCtD
Omeprazole—Headache—Hydroxyurea—brain cancer	0.000104	0.000898	CcSEcCtD
Omeprazole—Anaphylactic shock—Etoposide—brain cancer	0.000104	0.000896	CcSEcCtD
Omeprazole—CYP1A1—Metapathway biotransformation—CYP2C9—brain cancer	0.000104	0.0021	CbGpPWpGaD
Omeprazole—Infection—Etoposide—brain cancer	0.000103	0.00089	CcSEcCtD
Omeprazole—Urticaria—Temozolomide—brain cancer	0.000103	0.00089	CcSEcCtD
Omeprazole—CYP2C8—endocrine gland—brain cancer	0.000103	0.0113	CbGeAlD
Omeprazole—Abdominal pain—Temozolomide—brain cancer	0.000103	0.000885	CcSEcCtD
Omeprazole—Body temperature increased—Temozolomide—brain cancer	0.000103	0.000885	CcSEcCtD
Omeprazole—CYP11A1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000103	0.00208	CbGpPWpGaD
Omeprazole—CYP3A4—Irinotecan Pathway—APC—brain cancer	0.000102	0.00206	CbGpPWpGaD
Omeprazole—Thrombocytopenia—Etoposide—brain cancer	0.000102	0.000877	CcSEcCtD
Omeprazole—Tachycardia—Etoposide—brain cancer	0.000102	0.000875	CcSEcCtD
Omeprazole—CYP1B1—Aryl Hydrocarbon Receptor—RELA—brain cancer	0.000101	0.00206	CbGpPWpGaD
Omeprazole—Skin disorder—Etoposide—brain cancer	0.000101	0.00087	CcSEcCtD
Omeprazole—ABCC3—Fluoropyrimidine Activity—TP53—brain cancer	0.000101	0.00205	CbGpPWpGaD
Omeprazole—Hyperhidrosis—Etoposide—brain cancer	0.000101	0.000866	CcSEcCtD
Omeprazole—Anorexia—Etoposide—brain cancer	9.92e-05	0.000854	CcSEcCtD
Omeprazole—Hypersensitivity—Carmustine—brain cancer	9.92e-05	0.000854	CcSEcCtD
Omeprazole—ABCC3—Transmembrane transport of small molecules—S100A10—brain cancer	9.91e-05	0.00201	CbGpPWpGaD
Omeprazole—Nausea—Hydroxyurea—brain cancer	9.89e-05	0.000852	CcSEcCtD
Omeprazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	9.73e-05	0.00197	CbGpPWpGaD
Omeprazole—Asthenia—Carmustine—brain cancer	9.66e-05	0.000831	CcSEcCtD
Omeprazole—CYP1A2—endocrine gland—brain cancer	9.65e-05	0.0106	CbGeAlD
Omeprazole—CYP1B1—brain—brain cancer	9.63e-05	0.0105	CbGeAlD
Omeprazole—CYP2C8—Biological oxidations—CYP2C9—brain cancer	9.63e-05	0.00195	CbGpPWpGaD
Omeprazole—Hypersensitivity—Temozolomide—brain cancer	9.58e-05	0.000825	CcSEcCtD
Omeprazole—CYP1A1—endocrine gland—brain cancer	9.52e-05	0.0104	CbGeAlD
Omeprazole—CYP2C8—Metapathway biotransformation—CYP2C9—brain cancer	9.5e-05	0.00192	CbGpPWpGaD
Omeprazole—CYP1A1—head—brain cancer	9.4e-05	0.0103	CbGeAlD
Omeprazole—Paraesthesia—Etoposide—brain cancer	9.35e-05	0.000805	CcSEcCtD
Omeprazole—Asthenia—Temozolomide—brain cancer	9.33e-05	0.000804	CcSEcCtD
Omeprazole—Dyspnoea—Etoposide—brain cancer	9.28e-05	0.000799	CcSEcCtD
Omeprazole—Somnolence—Etoposide—brain cancer	9.25e-05	0.000797	CcSEcCtD
Omeprazole—Diarrhoea—Carmustine—brain cancer	9.21e-05	0.000793	CcSEcCtD
Omeprazole—Pruritus—Temozolomide—brain cancer	9.2e-05	0.000792	CcSEcCtD
Omeprazole—CYP2C9—endocrine gland—brain cancer	9.16e-05	0.01	CbGeAlD
Omeprazole—CYP1B1—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	9.14e-05	0.00185	CbGpPWpGaD
Omeprazole—CYP11A1—Corticotropin-releasing hormone—RELA—brain cancer	9.14e-05	0.00185	CbGpPWpGaD
Omeprazole—Decreased appetite—Etoposide—brain cancer	9.05e-05	0.000779	CcSEcCtD
Omeprazole—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	9.04e-05	0.00183	CbGpPWpGaD
Omeprazole—ABCG2—HIF-2-alpha transcription factor network—VEGFA—brain cancer	9e-05	0.00182	CbGpPWpGaD
Omeprazole—Gastrointestinal disorder—Etoposide—brain cancer	8.99e-05	0.000774	CcSEcCtD
Omeprazole—Fatigue—Etoposide—brain cancer	8.97e-05	0.000773	CcSEcCtD
Omeprazole—Dizziness—Carmustine—brain cancer	8.9e-05	0.000766	CcSEcCtD
Omeprazole—Constipation—Etoposide—brain cancer	8.9e-05	0.000766	CcSEcCtD
Omeprazole—Pain—Etoposide—brain cancer	8.9e-05	0.000766	CcSEcCtD
Omeprazole—Diarrhoea—Temozolomide—brain cancer	8.9e-05	0.000766	CcSEcCtD
Omeprazole—ABCG2—cerebellum—brain cancer	8.83e-05	0.00966	CbGeAlD
Omeprazole—ABCC3—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	8.64e-05	0.00175	CbGpPWpGaD
Omeprazole—Dizziness—Temozolomide—brain cancer	8.6e-05	0.000741	CcSEcCtD
Omeprazole—CYP2C19—Biological oxidations—CYP2C9—brain cancer	8.59e-05	0.00174	CbGpPWpGaD
Omeprazole—CYP1A1—central nervous system—brain cancer	8.58e-05	0.00938	CbGeAlD
Omeprazole—Feeling abnormal—Etoposide—brain cancer	8.58e-05	0.000738	CcSEcCtD
Omeprazole—Vomiting—Carmustine—brain cancer	8.56e-05	0.000737	CcSEcCtD
Omeprazole—Gastrointestinal pain—Etoposide—brain cancer	8.51e-05	0.000733	CcSEcCtD
Omeprazole—Rash—Carmustine—brain cancer	8.49e-05	0.000731	CcSEcCtD
Omeprazole—Dermatitis—Carmustine—brain cancer	8.48e-05	0.00073	CcSEcCtD
Omeprazole—CYP2C19—Metapathway biotransformation—CYP2C9—brain cancer	8.48e-05	0.00172	CbGpPWpGaD
Omeprazole—Headache—Carmustine—brain cancer	8.43e-05	0.000726	CcSEcCtD
Omeprazole—CYP1A2—Estrogen Receptor Pathway—STAT3—brain cancer	8.3e-05	0.00168	CbGpPWpGaD
Omeprazole—Vomiting—Temozolomide—brain cancer	8.27e-05	0.000712	CcSEcCtD
Omeprazole—Urticaria—Etoposide—brain cancer	8.27e-05	0.000712	CcSEcCtD
Omeprazole—Abdominal pain—Etoposide—brain cancer	8.23e-05	0.000708	CcSEcCtD
Omeprazole—Body temperature increased—Etoposide—brain cancer	8.23e-05	0.000708	CcSEcCtD
Omeprazole—CYP11A1—Corticotropin-releasing hormone—IL2—brain cancer	8.23e-05	0.00167	CbGpPWpGaD
Omeprazole—Rash—Temozolomide—brain cancer	8.2e-05	0.000706	CcSEcCtD
Omeprazole—Dermatitis—Temozolomide—brain cancer	8.19e-05	0.000705	CcSEcCtD
Omeprazole—Headache—Temozolomide—brain cancer	8.15e-05	0.000702	CcSEcCtD
Omeprazole—Nausea—Carmustine—brain cancer	8e-05	0.000688	CcSEcCtD
Omeprazole—CYP11A1—Corticotropin-releasing hormone—CTNNB1—brain cancer	7.94e-05	0.00161	CbGpPWpGaD
Omeprazole—CYP2D6—Biological oxidations—CYP2C9—brain cancer	7.9e-05	0.0016	CbGpPWpGaD
Omeprazole—ABCB1—telencephalon—brain cancer	7.84e-05	0.00858	CbGeAlD
Omeprazole—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—brain cancer	7.83e-05	0.00159	CbGpPWpGaD
Omeprazole—CYP2D6—Metapathway biotransformation—CYP2C9—brain cancer	7.8e-05	0.00158	CbGpPWpGaD
Omeprazole—CYP1B1—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	7.77e-05	0.00157	CbGpPWpGaD
Omeprazole—Nausea—Temozolomide—brain cancer	7.73e-05	0.000665	CcSEcCtD
Omeprazole—Hypersensitivity—Etoposide—brain cancer	7.67e-05	0.00066	CcSEcCtD
Omeprazole—CYP11A1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	7.51e-05	0.00152	CbGpPWpGaD
Omeprazole—Asthenia—Etoposide—brain cancer	7.47e-05	0.000643	CcSEcCtD
Omeprazole—CYP2C8—brain—brain cancer	7.38e-05	0.00807	CbGeAlD
Omeprazole—Pruritus—Etoposide—brain cancer	7.36e-05	0.000634	CcSEcCtD
Omeprazole—ABCG2—brain—brain cancer	7.17e-05	0.00785	CbGeAlD
Omeprazole—CYP1B1—Aryl Hydrocarbon Receptor—MYC—brain cancer	7.15e-05	0.00145	CbGpPWpGaD
Omeprazole—Diarrhoea—Etoposide—brain cancer	7.12e-05	0.000613	CcSEcCtD
Omeprazole—CYP1B1—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	6.99e-05	0.00142	CbGpPWpGaD
Omeprazole—CYP1B1—Aryl Hydrocarbon Receptor—EGFR—brain cancer	6.99e-05	0.00142	CbGpPWpGaD
Omeprazole—CYP3A4—endocrine gland—brain cancer	6.98e-05	0.00764	CbGeAlD
Omeprazole—ABCG2—Fluoropyrimidine Activity—TP53—brain cancer	6.96e-05	0.00141	CbGpPWpGaD
Omeprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	6.91e-05	0.0014	CbGpPWpGaD
Omeprazole—Dizziness—Etoposide—brain cancer	6.88e-05	0.000593	CcSEcCtD
Omeprazole—CYP2D6—endocrine gland—brain cancer	6.87e-05	0.00752	CbGeAlD
Omeprazole—ABCG2—Transmembrane transport of small molecules—S100A10—brain cancer	6.84e-05	0.00138	CbGpPWpGaD
Omeprazole—CYP1A1—brain—brain cancer	6.81e-05	0.00745	CbGeAlD
Omeprazole—CYP2D6—head—brain cancer	6.79e-05	0.00742	CbGeAlD
Omeprazole—CYP1A2—Biological oxidations—CYP2C9—brain cancer	6.7e-05	0.00136	CbGpPWpGaD
Omeprazole—Vomiting—Etoposide—brain cancer	6.62e-05	0.00057	CcSEcCtD
Omeprazole—CYP1A2—Metapathway biotransformation—CYP2C9—brain cancer	6.6e-05	0.00134	CbGpPWpGaD
Omeprazole—Rash—Etoposide—brain cancer	6.56e-05	0.000565	CcSEcCtD
Omeprazole—Dermatitis—Etoposide—brain cancer	6.56e-05	0.000565	CcSEcCtD
Omeprazole—CYP1B1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	6.55e-05	0.00133	CbGpPWpGaD
Omeprazole—ABCB1—gonad—brain cancer	6.54e-05	0.00716	CbGeAlD
Omeprazole—Headache—Etoposide—brain cancer	6.52e-05	0.000561	CcSEcCtD
Omeprazole—ABCB1—pituitary gland—brain cancer	6.38e-05	0.00698	CbGeAlD
Omeprazole—ABCC3—Metabolism of lipids and lipoproteins—IDH1—brain cancer	6.32e-05	0.00128	CbGpPWpGaD
Omeprazole—CYP3A4—central nervous system—brain cancer	6.29e-05	0.00689	CbGeAlD
Omeprazole—CYP1A1—Aryl Hydrocarbon Receptor—RELA—brain cancer	6.25e-05	0.00127	CbGpPWpGaD
Omeprazole—CYP2D6—central nervous system—brain cancer	6.19e-05	0.00678	CbGeAlD
Omeprazole—Nausea—Etoposide—brain cancer	6.18e-05	0.000532	CcSEcCtD
Omeprazole—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—brain cancer	6.18e-05	0.00125	CbGpPWpGaD
Omeprazole—ABCB1—medulla oblongata—brain cancer	6.16e-05	0.00674	CbGeAlD
Omeprazole—CYP2D6—cerebellum—brain cancer	6.05e-05	0.00662	CbGeAlD
Omeprazole—ABCB1—midbrain—brain cancer	5.63e-05	0.00616	CbGeAlD
Omeprazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	5.63e-05	0.00114	CbGpPWpGaD
Omeprazole—ABCB1—spinal cord—brain cancer	5.49e-05	0.00601	CbGeAlD
Omeprazole—ABCB1—Allograft Rejection—PDGFRA—brain cancer	5.34e-05	0.00108	CbGpPWpGaD
Omeprazole—ABCG2—HIF-1-alpha transcription factor network—VEGFA—brain cancer	5.29e-05	0.00107	CbGpPWpGaD
Omeprazole—CYP3A4—Biological oxidations—CYP2C9—brain cancer	5.17e-05	0.00105	CbGpPWpGaD
Omeprazole—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	5.1e-05	0.00103	CbGpPWpGaD
Omeprazole—ABCB1—endocrine gland—brain cancer	4.94e-05	0.00541	CbGeAlD
Omeprazole—CYP2D6—brain—brain cancer	4.92e-05	0.00538	CbGeAlD
Omeprazole—ABCB1—head—brain cancer	4.88e-05	0.00534	CbGeAlD
Omeprazole—CYP1B1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	4.79e-05	0.00097	CbGpPWpGaD
Omeprazole—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	4.78e-05	0.000969	CbGpPWpGaD
Omeprazole—ABCC3—Transmembrane transport of small molecules—TRPC6—brain cancer	4.58e-05	0.000927	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—CYP2C9—brain cancer	4.57e-05	0.000926	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	4.46e-05	0.000903	CbGpPWpGaD
Omeprazole—ABCB1—central nervous system—brain cancer	4.46e-05	0.00487	CbGeAlD
Omeprazole—CYP1A1—Aryl Hydrocarbon Receptor—MYC—brain cancer	4.4e-05	0.000891	CbGpPWpGaD
Omeprazole—ABCB1—cerebellum—brain cancer	4.35e-05	0.00476	CbGeAlD
Omeprazole—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—brain cancer	4.3e-05	0.000872	CbGpPWpGaD
Omeprazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	4.3e-05	0.000872	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	4.23e-05	0.000856	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	4.03e-05	0.000817	CbGpPWpGaD
Omeprazole—CYP1A2—Aryl Hydrocarbon Receptor—RELA—brain cancer	3.98e-05	0.000807	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—CYP2C9—brain cancer	3.96e-05	0.000801	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—BSG—brain cancer	3.89e-05	0.000787	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—CYP2C9—brain cancer	3.85e-05	0.000779	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	3.7e-05	0.000749	CbGpPWpGaD
Omeprazole—ABCB1—Transmembrane transport of small molecules—S100A10—brain cancer	3.7e-05	0.000749	CbGpPWpGaD
Omeprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	3.59e-05	0.000727	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	3.57e-05	0.000722	CbGpPWpGaD
Omeprazole—ABCB1—brain—brain cancer	3.54e-05	0.00387	CbGeAlD
Omeprazole—CYP2C18—Metabolism—BSG—brain cancer	3.36e-05	0.000681	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—IDH1—brain cancer	3.34e-05	0.000677	CbGpPWpGaD
Omeprazole—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—brain cancer	3.34e-05	0.000677	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	3.3e-05	0.000668	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—BSG—brain cancer	3.27e-05	0.000663	CbGpPWpGaD
Omeprazole—ABCG2—Transmembrane transport of small molecules—TRPC6—brain cancer	3.16e-05	0.000639	CbGpPWpGaD
Omeprazole—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	3.05e-05	0.000618	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.95e-05	0.000597	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	2.93e-05	0.000593	CbGpPWpGaD
Omeprazole—ABCB1—Allograft Rejection—IL2—brain cancer	2.92e-05	0.000591	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—CYP2C9—brain cancer	2.92e-05	0.000591	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—IDH1—brain cancer	2.89e-05	0.000586	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	2.87e-05	0.000582	CbGpPWpGaD
Omeprazole—ABCB1—HIF-1-alpha transcription factor network—VEGFA—brain cancer	2.86e-05	0.00058	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	2.84e-05	0.000575	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—IDH1—brain cancer	2.81e-05	0.00057	CbGpPWpGaD
Omeprazole—CYP1A2—Aryl Hydrocarbon Receptor—MYC—brain cancer	2.81e-05	0.000568	CbGpPWpGaD
Omeprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	2.74e-05	0.000556	CbGpPWpGaD
Omeprazole—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—brain cancer	2.74e-05	0.000556	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	2.72e-05	0.000551	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.7e-05	0.000547	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—CYP2C9—brain cancer	2.65e-05	0.000537	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—ENO2—brain cancer	2.64e-05	0.000535	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	2.64e-05	0.000534	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	2.57e-05	0.000521	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	2.51e-05	0.000509	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—BSG—brain cancer	2.48e-05	0.000502	CbGpPWpGaD
Omeprazole—ABCB1—Allograft Rejection—VEGFA—brain cancer	2.48e-05	0.000502	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.41e-05	0.000489	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	2.29e-05	0.000464	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—ENO2—brain cancer	2.29e-05	0.000463	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—BSG—brain cancer	2.26e-05	0.000457	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—ENO2—brain cancer	2.22e-05	0.00045	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.2e-05	0.000446	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	2.17e-05	0.00044	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—IDH1—brain cancer	2.13e-05	0.000432	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—APC—brain cancer	2.05e-05	0.000414	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—IDH1—brain cancer	1.94e-05	0.000393	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	1.88e-05	0.000381	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—CYP2C9—brain cancer	1.8e-05	0.000364	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.74e-05	0.000352	CbGpPWpGaD
Omeprazole—ABCB1—Transmembrane transport of small molecules—TRPC6—brain cancer	1.71e-05	0.000346	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—ENO2—brain cancer	1.69e-05	0.000341	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—CYP2C9—brain cancer	1.65e-05	0.000333	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	1.59e-05	0.000322	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—ENO2—brain cancer	1.53e-05	0.000311	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—BSG—brain cancer	1.53e-05	0.000309	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—CYP2C9—brain cancer	1.47e-05	0.000298	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—CYP2C9—brain cancer	1.43e-05	0.000291	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	1.4e-05	0.000284	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—BSG—brain cancer	1.4e-05	0.000284	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	1.39e-05	0.000281	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—CYP2C9—brain cancer	1.35e-05	0.000274	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—IDH1—brain cancer	1.31e-05	0.000266	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—BSG—brain cancer	1.25e-05	0.000253	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	1.22e-05	0.000248	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—BSG—brain cancer	1.22e-05	0.000247	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—PIK3CG—brain cancer	1.21e-05	0.000245	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—IDH1—brain cancer	1.2e-05	0.000244	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—BSG—brain cancer	1.15e-05	0.000233	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—CYP2C9—brain cancer	1.15e-05	0.000232	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—BSG—brain cancer	1.14e-05	0.000231	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	1.13e-05	0.000228	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	1.1e-05	0.000223	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—IDH1—brain cancer	1.07e-05	0.000218	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.07e-05	0.000217	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—IDH1—brain cancer	1.05e-05	0.000212	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—PIK3CG—brain cancer	1.05e-05	0.000212	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—ENO2—brain cancer	1.04e-05	0.00021	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—PIK3CG—brain cancer	1.02e-05	0.000207	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—IDH1—brain cancer	9.88e-06	0.0002	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	9.8e-06	0.000199	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—IDH1—brain cancer	9.8e-06	0.000198	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—BSG—brain cancer	9.74e-06	0.000197	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—ENO2—brain cancer	9.52e-06	0.000193	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	9.24e-06	0.000187	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—CYP2C9—brain cancer	8.84e-06	0.000179	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	8.75e-06	0.000177	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—ENO2—brain cancer	8.49e-06	0.000172	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—IDH1—brain cancer	8.37e-06	0.00017	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—ENO2—brain cancer	8.29e-06	0.000168	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	7.98e-06	0.000162	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—ENO2—brain cancer	7.81e-06	0.000158	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—ENO2—brain cancer	7.74e-06	0.000157	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—PIK3CG—brain cancer	7.73e-06	0.000157	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—BSG—brain cancer	7.51e-06	0.000152	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—PIK3CG—brain cancer	7.03e-06	0.000142	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	6.82e-06	0.000138	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—ENO2—brain cancer	6.62e-06	0.000134	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—IDH1—brain cancer	6.46e-06	0.000131	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—ENO2—brain cancer	5.11e-06	0.000103	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—PIK3CG—brain cancer	4.76e-06	9.64e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—PIK3CG—brain cancer	4.37e-06	8.84e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—PIK3CG—brain cancer	3.9e-06	7.89e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—PIK3CG—brain cancer	3.8e-06	7.7e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—PIK3CG—brain cancer	3.58e-06	7.26e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—PIK3CG—brain cancer	3.55e-06	7.2e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—PIK3CG—brain cancer	3.04e-06	6.15e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PIK3CG—brain cancer	2.34e-06	4.75e-05	CbGpPWpGaD
